Amnovis Acquires Westconn Precision’s Additive Manufacturing Activities

Amnovis Acquires WestConn AM Activities

Amnovis announces the establishment of a new operational entity in the United States and the acquisition of the additive manufacturing activities of Westconn Precision Technologies.

The new U.S. operations will be located in North Webster, Indiana, and directly within the ecosystem surrounding Warsaw, Indiana. The site is being developed as a mirror site of Amnovis’ Belgian headquarters, operating under the same global quality management system, procedures, digital workflows, validation frameworks and equipment strategy.

To lead the U.S. operations, Amnovis has appointed Chris Cook as General Manager, U.S. Operations. Cook brings extensive leadership experience across scale-ups and large international medical device organizations, and will oversee the ramp-up and operational execution of Amnovis’ U.S. manufacturing activities.

By establishing mirrored production sites in Europe and the United States under a single global quality management system, Amnovis enables customers to deploy manufacturing capacity across regions while maintaining consistent processes, equipment and validation approaches. This operating model is designed to support flexible and scalable manufacturing in regulated environments.

As part of its U.S. expansion, Amnovis has acquired the additive manufacturing activities of Westconn Precision Technologies. These activities will be integrated into Amnovis’ new U.S. operations in North Webster, Indiana, combining metal additive manufacturing with conventional CNC and post-processing technologies.

In support of this expansion, Jake Marasco will join Amnovis and take responsibility for account management and business development in North America. Marasco brings deep experience in integrating additive manufacturing into broader manufacturing workflows, with a strong focus on combining additive manufacturing and precision machining strategies.

“Expanding our operational footprint to the United States is a logical next step in the evolution of Amnovis,” said Ruben Wauthle, CEO and Co founder of Amnovis. “Being close to the largest medical device market globally, and specifically within the Warsaw, Indiana ecosystem, allows us to better support customers who require reliable, high quality additive manufacturing capacity with minimal logistical complexity.”

Source: Amnovis

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE